NeuroOne Medical Technologies Corporation (NMTC)Healthcare | Medical Devices | Eden Prairie, United States | NasdaqCM
4.84 USD
+0.27
(5.908%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 4.90 +0.06 (1.240%) ⇧ (April 17, 2026, 5:40 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 1:09 a.m. EDT
NeuroOne (NMTC) is a deep-value trap with no near-term catalyst other than volatility. While the wide reverse split and insider purchases are notable, the fundamentals are disastrous: negative revenue growth, bleeding cash, and a negative forward P/E. The options game is static 'long-wing' hedging, not a momentum trade. With a forecasting model predicting a ~5% drop over the next 45 days, added capital would likely face significant downside risk; this is currently an unsuitable investment for any timeframe. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.163085 |
| AutoARIMA | 0.163978 |
| MSTL | 0.170536 |
| AutoTheta | 0.250268 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.85 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.754 |
| Excess Kurtosis | -0.53 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.708 |
| Revenue per Share | 1.561 |
| Market Cap | 40,892,372 |
| Forward P/E | -17.29 |
| Beta | 0.58 |
| Profit Margins | -58.28% |
| Website | https://nmtc1.com |
As of April 19, 2026, 1:09 a.m. EDT: Options activity shows a pervasive 'long wing' positioning, with significant Open Interest (OI) concentrated at deep out-of-the-money strikes (e.g., $5.00 and $7.50 calls) despite very low Trading Volume. This indicates a hedge or speculation strategy for downside protection and long-term upside rather than immediate expiration. Implied Volatility (IV) is distorted, showing near-zero pricing for deep OTM calls in the April expiration, suggesting a lack of active pricing for those specific OTM strikes or a completed expiration cycle. High ITM put OI suggests active hedging by shareholders, consistent with the extremely high insurable value of the deep OTM calls.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.42269254 |
| Address1 | 7,599 Anagram Drive |
| All Time High | 180.0 |
| All Time Low | 2.37 |
| Ask | 4.94 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 71,731 |
| Average Daily Volume3 Month | 41,362 |
| Average Volume | 41,362 |
| Average Volume10Days | 71,731 |
| Beta | 0.578 |
| Bid | 4.78 |
| Bid Size | 1 |
| Book Value | 0.127 |
| City | Eden Prairie |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.84 |
| Current Ratio | 6.41 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.8999 |
| Day Low | 4.4207 |
| Debt To Equity | 3.708 |
| Display Name | NeuroOne Medical |
| Earnings Call Timestamp End | 1,771,335,000 |
| Earnings Call Timestamp Start | 1,771,335,000 |
| Earnings Timestamp | 1,771,335,000 |
| Earnings Timestamp End | 1,778,589,000 |
| Earnings Timestamp Start | 1,778,589,000 |
| Ebitda | -7,382,912 |
| Ebitda Margins | -0.63015 |
| Enterprise To Ebitda | -5.07 |
| Enterprise To Revenue | 3.195 |
| Enterprise Value | 37,433,404 |
| Eps Forward | -0.28 |
| Eps Trailing Twelve Months | -1.08 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.53484 |
| Fifty Day Average Change | 0.30516005 |
| Fifty Day Average Change Percent | 0.06729235 |
| Fifty Two Week Change Percent | 42.269253 |
| Fifty Two Week High | 6.96 |
| Fifty Two Week High Change | -2.12 |
| Fifty Two Week High Change Percent | -0.30459768 |
| Fifty Two Week Low | 3.21 |
| Fifty Two Week Low Change | 1.6300001 |
| Fifty Two Week Low Change Percent | 0.5077882 |
| Fifty Two Week Range | 3.21 - 6.96 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,521,120,600,000 |
| Float Shares | 7,749,005 |
| Forward Eps | -0.28 |
| Forward P E | -17.285715 |
| Free Cashflow | -3,917,580 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.22034 |
| Gross Profits | 2,581,531 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14385 |
| Held Percent Institutions | 0.24677 |
| Implied Shares Outstanding | 8,448,837 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-05-26 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,759,190,400 |
| Last Split Date | 1,776,297,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota. |
| Long Name | NeuroOne Medical Technologies Corporation |
| Market | us_market |
| Market Cap | 40,892,372 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_412033082 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -6,828,586 |
| Next Fiscal Year End | 1,790,726,400 |
| Non Diluted Market Cap | 40,976,854 |
| Number Of Analyst Opinions | 3 |
| Open | 4.57 |
| Operating Cashflow | -6,161,156 |
| Operating Margins | -0.59023 |
| Payout Ratio | 0.0 |
| Phone | 952 426 1383 |
| Post Market Change | 0.059999943 |
| Post Market Change Percent | 1.2396683 |
| Post Market Price | 4.9 |
| Post Market Time | 1,776,462,010 |
| Previous Close | 4.57 |
| Price Hint | 4 |
| Price To Book | 38.110237 |
| Price To Sales Trailing12 Months | 3.4902537 |
| Profit Margins | -0.58283 |
| Quick Ratio | 4.945 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.27 |
| Regular Market Change Percent | 5.9081 |
| Regular Market Day High | 4.8999 |
| Regular Market Day Low | 4.4207 |
| Regular Market Day Range | 4.4207 - 4.8999 |
| Regular Market Open | 4.57 |
| Regular Market Previous Close | 4.57 |
| Regular Market Price | 4.84 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 197,129 |
| Return On Assets | -0.63404 |
| Return On Equity | -1.4626601 |
| Revenue Growth | -0.117 |
| Revenue Per Share | 1.561 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 8,448,836 |
| Shares Percent Shares Out | 0.0023999999 |
| Shares Short | 19,937 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 17,911 |
| Short Name | NeuroOne Medical Technologies C |
| Short Percent Of Float | 0.0023999999 |
| Short Ratio | 0.63 |
| Source Interval | 15 |
| State | MN |
| Symbol | NMTC |
| Target High Price | 18.0 |
| Target Low Price | 9.0 |
| Target Mean Price | 12.2 |
| Target Median Price | 9.6 |
| Total Cash | 3,561,616 |
| Total Cash Per Share | 0.423 |
| Total Debt | 237,377 |
| Total Revenue | 11,716,160 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.08 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.74523 |
| Two Hundred Day Average Change | 0.094769955 |
| Two Hundred Day Average Change Percent | 0.019971624 |
| Type Disp | Equity |
| Volume | 197,129 |
| Website | https://nmtc1.com |
| Zip | 55,344 |